Regulatory Updates
Aug 31, 2026•1 min read
Il Dong Pharmaceutical Group Conducts Fair Trade Law Training for All Employees
Il Dong Pharmaceutical Group, with the Korea Fair Trade Mediation Agency, delivered practical fair‑trade law training to all staff on May 8, aiming to strengthen self‑compliance culture and compliance management.
Regulatory Updates
Aug 31, 2026•1 min read
South Korea Introduces Bill to Ban Warehouse‑Type Pharmacies
A draft amendment to the Pharmacy Act aims to prohibit 'warehouse‑type' pharmacies, citing concerns over external capital influence and loss of pharmacy independence.
Regulatory Updates
Aug 31, 2026•1 min read
Myeongin Pharma Advances Parkinson’s Drug P2B001 Toward Korean Approval
Myeongin Pharma seeks Korean approval for P2B001, the world’s first extended‑release Parkinson’s combination drug, as it shifts toward global R&D.
1
Regulatory Updates
Aug 31, 2026•1 min read
창고형 약국 방지법 조만간 발의 예정
외부 자본이 개입한 '창고형 약국'을 차단하기 위한 법안이 곧 발의돼 약국 독립성과 공공성 확보가 논의됩니다.
16
Regulatory Updates
Aug 31, 2026•1 min read
Keytruda gains two Korean approvals, adds bladder, ovarian uses
MSD Korea received MFDS approval for two additional Keytruda combination therapy indications, bringing its Korean portfolio to 5 bladder and 2 ovarian cancer indications, covering 18 cancers and 37 indications overall.
Regulatory Updates
Aug 31, 2026•1 min read
Korean Health Ministry appoints Kim Hyun-sook as Population and Child Policy Director
On July 10, 2026, the Korean Ministry of Health and Welfare announced the director‑level transfer of Kim Hyun-sook to the role of Population and Child Policy Officer.
Regulatory Updates
Aug 31, 2026•1 min read
Curocell’s Limkato CAR‑T Therapy Passes First Health‑Insurance Review in Korea
Korea’s first CAR‑T drug Limkato has cleared its initial health‑insurance coverage review, paving the way for prescriptions and sales from the second half of 2024.
Regulatory Updates
Aug 31, 2026•1 min read
Regulatory inspections reveal rising PDRN use in Korean cosmetics
Inspections by Korea's MFDS show a sharp increase in companies labeling skin‑boosting cosmetics with PDRN, rising from 7 cases in 2023 to 39 in 2025.
Regulatory Updates
Aug 30, 2026•1 min read
Report Calls for Strengthening National University Hospitals and Regional Care
A recent National Assembly Budget Office report recommends boosting national university hospitals and reorganizing regional responsibility medical systems, which could benefit nearby pharmacies.
Regulatory Updates
Aug 30, 2026•1 min read
Korean Court Overturns Rejection of Jointstem Stem Cell Therapy for Osteoarthritis
Seoul Administrative Court ruled in favor of R&L Regenerative Medicine, canceling the MFDS’s 2025 rejection of Jointstem, a stem‑cell treatment for osteoarthritis.
Regulatory Updates
Aug 30, 2026•1 min read
Policy Report Calls for Reassessment of Convenience Store OTC Medicine Expansion in Korea
A Korean pharmacists' group urges scaling back the convenience‑store standby drug system after the key product 지사제 is barred for under‑19 use.
Regulatory Updates
Aug 30, 2026•1 min read
Lawmakers Propose Nursing Act Amendment to Address Workplace Bullying in Korea
Lawmaker Lee Soo-jin introduced a bill to empower the Nursing Workforce Support Center to prevent and aid recovery from workplace bullying, after a nurse's death linked to such abuse.